Results 241 to 250 of about 87,709 (275)

Gabapentin augmentation therapy in bipolar depression

Bipolar Disorders, 2002
Background:  Gabapentin (GBP) may be useful in bipolar disorders, including as adjunctive therapy for bipolar depression, although controlled studies suggest inefficacy as primary treatment for mania or treatment‐resistant rapid cycling.Methods:  We performed a 12‐week trial of open GBP (mean dose 1725 mg/day) added to stable doses of mood stabilizers ...
Po W, Wang, Claudia, Santosa, Matthew, Schumacher, Mirene E, Winsberg, Connie, Strong, Terence A, Ketter   +5 more
openaire   +2 more sources

Augmentation of standard depression therapy

Clinical Therapeutics, 2000
This article reviews treatment options (eg, augmentation) for depressed patients with suboptimal clinical responses to an antidepressant.Approximately one third of patients treated with antidepressants exhibit suboptimal or delayed clinical response to these medications.
openaire   +2 more sources

THERADIA: Digital Therapies Augmented by Artificial Intelligence

2021
Digital plays a key role in the transformation of medicine. Beyond the simple computerisation of healthcare systems, many non-drug treatments are now possible thanks to digital technology. Thus, interactive stimulation exercises can be offered to people suffering from cognitive disorders, such as developmental disorders, neurodegenerative diseases ...
Tarpin-Bernard, Franck, Fruitet, Joan, Vigne, Jean-Philippe, Constant, Patrick, Chainay, Hanna, Koenig, Olivier, Ringeval, Fabien, Bouchot, Béatrice, Bailly, Gérard, Portet, François, Alisamir, Sina, Zhou, Yongxin, Serre, Jean, Delerue, Vincent, Fournier, Hippolyte, Berenger, Kévin, Zsoldos, Isabella, Perrotin, Olivier, Elisei, Frédéric, Lenglet, Martin, Puaux, Charles, Pacheco, Léo, Fouillen, Mélodie, Ghenassia, Didier   +23 more
openaire   +3 more sources

Pindolol Augmentation of Antidepressant Therapy

The Australian Journal of Hospital Pharmacy, 1999
To review the safety and efficacy of pindolol in augmenting the response to antidepressant drugs.
Christopher P Alderman, Tania Colarco
openaire   +1 more source

Alpha1-Antitrypsin Augmentation Therapy

1993
Alpha 1-proteinase inhibitor (also known as alpha 1-antitrypsin) derived from pooled human serum (Prolastin, Miles Biologicals) has been available in the United States since 1988. Although no formal controlled prospective study has been performed to prove its efficacy, intravenous administration of Prolastin has been the accepted treatment for ...
openaire   +2 more sources

Augmentation of Electroconvulsive Therapy Seizures With Sleep Deprivation

The Journal of ECT, 2004
Electroconvulsive therapy (ECT) is the fastest and most effective treatment for severe or treatment-resistant affective and psychotic disorders. Its therapeutic effect is obtained through a generalized tonic-clonic seizure of adequate duration. Several factors (older age, male gender, and the sessions of ECT themselves) increase seizure threshold and ...
Ester, Gilabert, Emilio, Rojo, Julio, Vallejo   +2 more
openaire   +2 more sources

Error-augmented bimanual therapy for stroke survivors

NeuroRehabilitation, 2018
BACKGROUND: Stroke recovery studies have shown the efficacy of bimanual training on upper limb functional recovery and others have shown the efficacy of feedback technology that augments error. OBJECTIVE: In a double-blinded randomized controlled study (N = 26), we evaluated the short-term effects of bilateral arm training to foster functional recovery
Farnaz, Abdollahi, Molly, Corrigan, Emily D C, Lazzaro, Robert V, Kenyon, James L, Patton   +4 more
openaire   +3 more sources

Acamprosate Calcium as Augmentation Therapy for Anxiety Disorders

Annals of Pharmacotherapy, 2010
Background: Glutamate is a major excitatory neurotransmitter, while γ-aminobutyric acid (GABA) is a predominant inhibitory neurotransmitter in the central nervous system. This GABA-glutamate imbalance is thought to play a role in the development of anxiety. Acamprosate calcium is thought to restore this chemical
Thomas L, Schwartz, Umar A, Siddiqui, Shafi, Raza, Anne, Costello   +3 more
openaire   +2 more sources

Augmenting Agents in Cancer Therapy

JAMA: The Journal of the American Medical Association, 1981
The title of this book implies that there are chemicals or biologic materials, augmenting agents, that work by enhancing the activity of other forms of therapy rather than through any direct effect themselves. In fact, the volume is an encyclopedia of many disparate kinds of natural or synthetic products that work directly or through the immune system ...
openaire   +1 more source

Augmentation Therapy with Alpha1-antitrypsin: Novel Perspectives

Cardiovascular & Hematological Disorders-Drug Targets, 2013
SERPINA1, α-antitrypsin (AAT) is an acute phase protein, a member of the serpin (serine protease inhibitor) super family and one of the most abundant protease inhibitors in the circulation. The clinical importance of AAT is emphasized in persons with inherited AAT deficiency who exhibit high risk of developing early onset pulmonary emphysema, neonatal ...
Janciauskiene, Sabina, Welte, Tobias
openaire   +2 more sources